Therapy for the dangerous infectious disease of tuberculosis faces the challenge of pathogens frequently being resistant to several common antibiotics. Researchers of Karlsruhe Institute of Technology (KIT) have now developed nanoparticles to deliver new antibiotics directly to the lungs.
Click here for original story, Tuberculosis therapy: Smallest particles could deliver drugs to the lungs
Source: Phys.org